Cargando…

25. OLIGODENDROCYTE-BASED IMPAIRMENT OF BRAIN CONNECTIVITY AS TARGET FOR NEW TREATMENT STRATEGIES IN SCHIZOPHRENIA

Overall Abstract: This symposium has a translational approach. First, we present human post-mortem and in-vivo imaging studies on the pivotal role of oligedondrocyte loss and dysfunction with consecutive impairments of brain connectivity in schizophrenia. Natalya Uranova will show morphometric data...

Descripción completa

Detalles Bibliográficos
Autor principal:	Steiner, Johann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888250/ http://dx.doi.org/10.1093/schbul/sby014.100

Ejemplares similares

25.1 OLIGODENDROCYTE PATHOLOGY IN PREFRONTAL WHITE MATTER IN SCHIZOPHRENIA
por: Uranova, Natalya, et al.
Publicado: (2018)

25.3 OLIGODENDROCYTES MEDIATE ENERGY METABOLISM ALTERATIONS IN SCHIZOPHRENIA: A PROTEOMIC STUDY
por: Martins-De-Souza, Daniel
Publicado: (2018)

Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia
por: Gouvêa-Junqueira, Danielle, et al.
Publicado: (2020)

Oligodendrocyte and Interneuron Density in Hippocampal Subfields in Schizophrenia and Association of Oligodendrocyte Number with Cognitive Deficits
por: Falkai, Peter, et al.
Publicado: (2016)

Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction
por: Raabe, Florian J., et al.
Publicado: (2019)

10.2 REDOX DYSREGULATION, OLIGODENDROCYTES AND WHITE MATTER ALTERATIONS IN SCHIZOPHRENIA
por: Klauser, Paul, et al.
Publicado: (2018)

Oligodendrocytes in Schizophrenia
por: Xu, Haiyun, et al.
Publicado: (2011)

13.3 EFFECTS OF CANNABINOIDS ON A HUMAN OLIGODENDROCYTE CULTURE: IMPLICATIONS FOR SCHIZOPHRENIA
por: Almeida, Valéria, et al.
Publicado: (2018)

F198. EFFECTS OF CANNABINOIDS ON A HUMAN OLIGODENDROCYTE CULTURE: IMPLICATIONS FOR SCHIZOPHRENIA
por: Almeida, Valéria, et al.
Publicado: (2018)

Treatment of Cognitive Impairment in Schizophrenia
por: Vita, A.
Publicado: (2022)

MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia
por: Guest, Paul C., et al.
Publicado: (2015)

F169. BRAIN CONNECTIVITY DURING PSYCHOLOGICAL STRESS IN PATIENTS WITH SCHIZOPHRENIA
por: Castro, Mariana, et al.
Publicado: (2018)

Discussion on Assessment and Treatment of Cognitive Impairment and New Developments of Cognitive Remediation in Schizophrenia
por: Wykes, T.
Publicado: (2022)

EPA guidance on treatment of cognitive impairment in schizophrenia
por: Vita, A.
Publicado: (2023)

F201. KINASE NETWORK DYSREGULATION IN SCHIZOPHRENIA: IMPLICATIONS FOR NEW TREATMENT STRATEGIES
por: Bentea, Eduard, et al.
Publicado: (2018)

Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules
por: Cassoli, Juliana Silva, et al.
Publicado: (2015)

Impairment of motivation in patients with schizophrenia and the development of a program for their psychosocial treatment
por: Mitikhin, V., et al.
Publicado: (2021)

T157. FRONTOSTRIATAL CONNECTIVITY IN TREATMENT-RESISTANT SCHIZOPHRENIA: RELATIONSHIP TO POSITIVE SYMPTOMS AND COGNITIVE FLEXIBILITY
por: Cropley, Vanessa, et al.
Publicado: (2018)

T176. REDUCED WHITE MATTER ‘CONNECTIVITY’ IN THE SPLENIUM OF THE CORPUS CALLOSUM IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Assunção-Leme, Idaiane, et al.
Publicado: (2018)

Interrelation of visual and olfactory impairments in schizophrenia
por: Tumova, M., et al.
Publicado: (2021)

Recognition and Assessment of Cognitive Impairment in Schizophrenia
por: Mucci, A., et al.
Publicado: (2022)

Cannabis use and cognitive impairment in schizophrenia
por: Gonçalves, M., et al.
Publicado: (2022)

Replenishing the Aged Brains: Targeting Oligodendrocytes and Myelination?
por: Zhang, Xi, et al.
Publicado: (2021)

Editorial: New insights into the disorder of brain connectivity in schizophrenia
por: Li, Weikai, et al.
Publicado: (2023)

S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA
por: Kim, Seoyoung, et al.
Publicado: (2018)

Cognitive impairment in treatment-refractory schizophrenia and type i diabetes. A case
por: Rodriguez, L. Soldado, et al.
Publicado: (2021)

43.3 COMPLEMENT DYSREGULATION IN SCHIZOPHRENIA: IMPLICATIONS FOR POTENTIAL TREATMENT STRATEGIES
por: Beasley, Clare
Publicado: (2018)

Graph-based analysis of brain connectivity in schizophrenia
por: Olejarczyk, Elzbieta, et al.
Publicado: (2017)

Functional connectivity between brain regions underlying executive control and language in schizophrenia patients with history of auditory verbal hallucinations
por: Panikratova, Y., et al.
Publicado: (2021)

Functional connectivity between brain regions underlying executive control and language in schizophrenia patients with history of auditory verbal hallucination
por: Panikratova, Y., et al.
Publicado: (2021)

T148. THALAMIC-CORTICAL CONNECTIVITY IN PATIENTS WITH AUDITORY HALLUCINATIONS IN SCHIZOPHRENIA
por: Zaytseva, Yulia, et al.
Publicado: (2018)

O6.5. LINKING CORTICAL AND CONNECTIONAL PATHOLOGY IN SCHIZOPHRENIA
por: Di Biase, Maria, et al.
Publicado: (2018)

Impaired age self-consciousness in latent schizophrenia
por: Suleimanov, R., et al.
Publicado: (2021)

MHV-JHM infection in immortalized murine oligodendrocytes()
por: Gilmore, W., et al.
Publicado: (1994)

S167. ANATOMICAL CONNECTIVITY OF THE VISUOSPATIAL ATTENTIONAL NETWORK IN SCHIZOPHRENIA: A DTI-BASED TRACTOGRAPHY STUDY
por: Elise, Leroux, et al.
Publicado: (2018)

Chd8 mutation in oligodendrocytes alters microstructure and functional connectivity in the mouse brain
por: Kawamura, Atsuki, et al.
Publicado: (2020)

Monosynaptic tracing maps brain-wide afferent oligodendrocyte precursor cell connectivity
por: Mount, Christopher W, et al.
Publicado: (2019)

T142. PARIETAL CONNECTIVITY IN SCHIZOPHRENIA AND PSYCHOTIC BIPOLAR DISORDER: A COMBINED STRUCTURAL AND DYNAMIC FUNCTIONAL CONNECTIVITY STUDY
por: Das, Tushar, et al.
Publicado: (2018)

Oligodendrocytes in the aging brain
por: Sams, Eleanor Catherine
Publicado: (2021)

Rituximab for treatment-resistant schizophrenia and/or obsessive-compulsive disorder (OCD): functional connectivity and cytokines associated with symptomatic improvements
por: Humble, M. B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k47c7q943qhrdtn76ojamvorld